Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 1c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q1 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance